BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 5
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11821)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.
Item 
Count 
PDF816
WORD289
HTML8307
Tables (1-2)276
 Sum=9688
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1097
Download1036
 Sum=2133
May 27, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6(5): 274-283 [PMID: 24868321 DOI: 10.4254/wjh.v6.i5.274]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/274.htm
Number Citing Articles
1
Hwi Jin Im, Yo Chan Ahn, Jing-Hua Wang, Myung Min Lee, Chang Gue Son. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101526 doi: 10.1016/j.clinre.2020.06.022
2
Mengting Zhang, Dongchun Chang, Qing Guan, Rui Dong, Ru Zhang, Wei Zhang, Hongliang Wang, Jie Wang. High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01457-y
3
Sophie E. Kastberg, Helene S. Lund, Emanuella De Lucia‐Rolfe, Lydia U. Kaduka, Michael K. Boit, Eva Corpeleijn, Henrik Friis, Sophie Bernard, Martine Paquette, Alexis Baass, Jon J. Rasmussen, Dirk L. Christensen. Hepatic steatosis is associated with anthropometry, cardio‐metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. Tropical Medicine & International Health 2022; 27(1): 49 doi: 10.1111/tmi.13696
4
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 21 doi: 10.1007/978-3-319-20538-0_2
5
Ibrahim Aldoss, Dan Douer, Carolyn E. Behrendt, Preeti Chaudhary, Ann Mohrbacher, Janice Vrona, Vinod Pullarkat. Toxicity profile of repeated doses of PEG‐asparaginase incorporated into a pediatric‐type regimen for adult acute lymphoblastic leukemia. European Journal of Haematology 2016; 96(4): 375 doi: 10.1111/ejh.12600
6
Manuel Garcia-Jaramillo, Melinda H. Spooner, Christiane V. Löhr, Carmen P. Wong, Weijian Zhang, Donald B. Jump, Hervé Guillou. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice. PLOS ONE 2019; 14(4): e0214387 doi: 10.1371/journal.pone.0214387
7
Hui Guan, Guangrui Shao, Fang Cheng, Pingjuan Ni, Mei Wu. Risk factors of nonalcoholic fatty liver disease in healthy women. Medicine 2023; 102(31): e34437 doi: 10.1097/MD.0000000000034437
8
Kayla L. Frey, M. Chandler McLeod, Robert M. Cannon, Saulat S. Sheikh, Joshua W. Purvis, Jayme E. Locke, Babak J. Orandi. Non-invasive evaluation of hepatic macrosteatosis in deceased donors. The American Journal of Surgery 2023; 226(5): 692 doi: 10.1016/j.amjsurg.2023.07.036
9
Huixin Liu, Jinlei Qi, Jia Yang, Feng Liu, Xiaohe Li, Peng Yin, Lijun Wang, Zhisheng Liang, Lai Wei, Huiying Rao, Maigeng Zhou. Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019. Diabetes, Obesity and Metabolism 2023; 25(S1): 43 doi: 10.1111/dom.15010
10
Xinxin Zhang, Jinfeng Xiao, Qi Liu, Yuanyuan Ye, Weihong Guo, Jingqiu Cui, Qing He, Wenli Feng, Ming Liu, Ma Gorzata Kotula Balak. Low Serum Total Testosterone Is Associated with Non-Alcoholic Fatty Liver Disease in Men but Not in Women with Type 2 Diabetes Mellitus. International Journal of Endocrinology 2022; 2022: 1 doi: 10.1155/2022/8509204
11
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. British Journal of Biomedical Science 2019; 76(2): 70 doi: 10.1080/09674845.2019.1571555
12
Saryia Adra, Yousef Alabrach, Anas Hashem, Amir Mahmoud, Amani Khalouf, Ahmed El-khapery, Ali Abdelhay, Mohamad Mansour, Batool Aldaher, Hiba Barqawi, Eman Abu-Gharbieh, Atsushi Hosui. Trends of primary liver cancer incidence and mortality in the United States: A population-based study over the last four decades. PLOS ONE 2024; 19(9): e0309465 doi: 10.1371/journal.pone.0309465
13
Jen-Jung Pan, Susan P Fisher-Hoch, Chaoru Chen, Ariel E Feldstein, Joseph B McCormick, Mohammad H Rahbar, Laura Beretta, Michael B Fallon. Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. World Journal of Hepatology 2015; 7(11): 1586-1594 doi: 10.4254/wjh.v7.i11.1586
14
Jed Friedman, Peter Russell Baker. Fetal and Neonatal Physiology. 2017; : 160 doi: 10.1016/B978-0-323-35214-7.00015-9
15
Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. Nutrients 2020; 12(6): 1819 doi: 10.3390/nu12061819
16
Maret G Traber, Eunice Mah, Scott W Leonard, Gerd Bobe, Richard S Bruno. Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial. The American Journal of Clinical Nutrition 2017; 105(3): 571 doi: 10.3945/ajcn.116.138495
17
Huei-Wen Lim, David E. Bernstein. Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. Clinics in Liver Disease 2018; 22(1): 39 doi: 10.1016/j.cld.2017.08.008
18
Na-Ling Kang, Jie-Min Zhang, Yu-Rui Liu, Su Lin, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu, Da-Wu Zeng. Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection. Clinics and Research in Hepatology and Gastroenterology 2020; 44(1): 57 doi: 10.1016/j.clinre.2019.04.001
19
Christian L. Herrera, Wilma Castillo, Patricia Estrada, Bárbara Mancilla, Gerardo Reyes, Nicolás Saavedra, Neftalí Guzmán, Pamela Serón, Fernando Lanas, Luis A. Salazar. Association of polymorphisms within the Renin-Angiotensin System with metabolic syndrome in a cohort of Chilean subjects. Archives of Endocrinology and Metabolism 2016; 60(3): 190 doi: 10.1590/2359-3997000000134
20
Hai Duc Nguyen, Min-Sun Kim. Cadmium, lead, and mercury mixtures interact with non-alcoholic fatty liver diseases. Environmental Pollution 2022; 309: 119780 doi: 10.1016/j.envpol.2022.119780
21
Omobonike O Oloruntoba, Cynthia A Moylan. Gender-based disparities in access to and outcomes of liver transplantation. World Journal of Hepatology 2015; 7(3): 460-467 doi: 10.4254/wjh.v7.i3.460
22
Yousef Fazel, Aaron B. Koenig, Mehmet Sayiner, Zachary D. Goodman, Zobair M. Younossi. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016; 65(8): 1017 doi: 10.1016/j.metabol.2016.01.012
23
Naomi Fearon, Dimitri J. Pournaras. Obesity, Bariatric and Metabolic Surgery. 2023; : 1005 doi: 10.1007/978-3-030-60596-4_107
24
Adam C. Sheka, Oyedele Adeyi, Julie Thompson, Bilal Hameed, Peter A. Crawford, Sayeed Ikramuddin. Nonalcoholic Steatohepatitis. JAMA 2020; 323(12): 1175 doi: 10.1001/jama.2020.2298
25
Tiziana Ciarambino, Pietro Crispino, Gaetano Leto, Erika Mastrolorenzo, Ombretta Para, Mauro Giordano. Influence of Gender in Diabetes Mellitus and Its Complication. International Journal of Molecular Sciences 2022; 23(16): 8850 doi: 10.3390/ijms23168850
26
Jinxiu Li, Shang Wang, Ling Yao, Peng Ma, Zhiwei Chen, Ting-Li Han, Chunlin Yuan, Jun Zhang, Lirong Jiang, Li Liu, Dazhi Ke, Chunli Li, Johji Yamahara, Yuhao Li, Jianwei Wang. 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. Toxicology and Applied Pharmacology 2019; 362: 125 doi: 10.1016/j.taap.2018.11.001
27
Mark Yu Zheng Wong, Jonathan Jiunn Liang Yap, Rehena Sultana, Mark Cheah, George Boon Bee Goh, Khung Keong Yeo. Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis. Open Heart 2021; 8(2): e001850 doi: 10.1136/openhrt-2021-001850
28
Livianna Carrieri, Alberto Osella, Fausto Ciccacci, Gianluigi Giannelli, Maria Scavo. Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine. Biomedicines 2022; 10(5): 1184 doi: 10.3390/biomedicines10051184
29
Meng Yang, Feng Ma, Min Guan. Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(5): 320 doi: 10.3390/metabo11050320
30
Hai Duc Nguyen, Min-Sun Kim. Effects of chemical mixtures on liver function biomarkers in the Korean adult population: thresholds and molecular mechanisms for non-alcoholic fatty liver disease involved. Environmental Science and Pollution Research 2022; 29(52): 78555 doi: 10.1007/s11356-022-21090-4
31
Peter L. M. Jansen, Kai Breuhahn, Andreas Teufel, Steven Dooley. Editorial: Systems Biology and Bioinformatics in Gastroenterology and Hepatology. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01438
32
Melinda H. Spooner, Donald B. Jump. Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use. Annual Review of Nutrition 2023; 43(1): 199 doi: 10.1146/annurev-nutr-061021-030223
33
Albert Do, Ysabel C. Ilagan‐Ying, Tamar H. Taddei. Analysis of weekend effect in severe acute liver injury: A nationwide database study. Health Science Reports 2020; 3(1) doi: 10.1002/hsr2.139
34
Óscar Soto-Angona, Gerard Anmella, María José Valdés-Florido, Nieves De Uribe-Viloria, Andre F. Carvalho, Brenda W. J. H. Penninx, Michael Berk. Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. BMC Medicine 2020; 18(1) doi: 10.1186/s12916-020-01713-8
35
Shivakumar Chitturi, Geoffrey C. Farrell. Textbook of Diabetes. 2017; : 745 doi: 10.1002/9781118924853.ch51
36
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
37
Avica Atri, Stephen A Jiwanmall, Munaf B Nandyal, Dheeraj Kattula, Sandhiya Paravathareddy, Thomas V Paul, Nihal Thomas, Nitin Kapoor. The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern India. European Endocrinology 2020; 16(2): 152 doi: 10.17925/EE.2020.16.2.152
38
Giovanni Tarantino, Carmine Finelli. Systematic review on Intervention with Prebiotics/Probiotics in Patients with Obesity-Related Nonalcoholic Fatty liver Disease. Future Microbiology 2015; 10(5): 889 doi: 10.2217/fmb.15.13
39
Changyu Zhu, KyeongJin Kim, Xiaobo Wang, Alberto Bartolome, Marcela Salomao, Paola Dongiovanni, Marica Meroni, Mark J. Graham, Katherine P. Yates, Anna Mae Diehl, Robert F. Schwabe, Ira Tabas, Luca Valenti, Joel E. Lavine, Utpal B. Pajvani. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine 2018; 10(468) doi: 10.1126/scitranslmed.aat0344
40
Gashaw Abebe, Daniel Ayanaw, Tiget Ayelgn Mengstie, Gashaw Dessie, Tabarak Malik. Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. SAGE Open Medicine 2022; 10 doi: 10.1177/20503121221124762
41
Abdulrahman Ismaiel, Oana Sabina Ciobanu, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Liliana David, Dilara Ensar, Nahlah Al Srouji, Dan L. Dumitrascu. Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Biomedicines 2022; 10(9): 2101 doi: 10.3390/biomedicines10092101
42
George B.B. Goh, Clarence Kwan, Sze Ying Lim, Nanda KK Venkatanarasimha, Rafidah Abu-Bakar, Thinesh L Krishnamoorthy, Hang Hock Shim, Kiang Hiong Tay, Wan Cheng Chow. Perceptions of non-alcoholic fatty liver disease – an Asian community-based study. Gastroenterology Report 2016; 4(2): 131 doi: 10.1093/gastro/gov047
43
Julia J. Wattacheril, Srilakshmi Raj, David A. Knowles, John M. Greally, Gregory P. Copenhaver. Using epigenomics to understand cellular responses to environmental influences in diseases. PLOS Genetics 2023; 19(1): e1010567 doi: 10.1371/journal.pgen.1010567
44
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
45
Zachary W. Patinkin, Richard Feinn, Melissa Santos. Metabolic Consequences of Obstructive Sleep Apnea in Adolescents with Obesity: A Systematic Literature Review and Meta-Analysis. Childhood Obesity 2017; 13(2): 102 doi: 10.1089/chi.2016.0248
46
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
47
Kiley B. Vander Wyst, Micah L. Olson, Smita S. Bailey, Ana Martinez Valencia, Armando Peña, Jeffrey Miller, Mitchell Shub, Lee Seabrooke, Janiel Pimentel, Kiri Olsen, Robert B. Rosenberg, Gabriel Q. Shaibi. Communicating incidental and reportable findings from research MRIs: considering factors beyond the findings in an underrepresented pediatric population. BMC Medical Research Methodology 2021; 21(1) doi: 10.1186/s12874-021-01459-8
48
Noble Kumar Talari, Ushodaya Mattam, Dorota Kaminska, Irene Sotomayor-Rodriguez, Afra P. Rahman, Miklós Péterfy, Päivi Pajukanta, Jussi Pihlajamäki, Karthickeyan Chella Krishnan. Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis. iScience 2024; 27(5): 109709 doi: 10.1016/j.isci.2024.109709
49
Ueamporn Summart, Bandit Thinkhamrop, Nittaya Chamadol, Narong Khuntikeo, Metha Songthamwat, Christina Sunyoung Kim. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Research 2017; 6: 1630 doi: 10.12688/f1000research.12417.2
50
Alessandro Leone, Alberto Battezzati, Giorgio Bedogni, Laila Vignati, Angelo Vanzulli, Ramona De Amicis, Andrea Foppiani, Simona Bertoli. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019; 11(12): 3008 doi: 10.3390/nu11123008
51
Zobair M. Younossi, Linda Henry, Haley Bush, Alita Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 1 doi: 10.1016/j.cld.2017.08.001
52
Takuya Fukuda, Masahide Hamaguchi, Takao Kojima, Kazuteru Mitsuhashi, Yoshitaka Hashimoto, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. European Journal of Gastroenterology & Hepatology 2016; 28(12): 1443 doi: 10.1097/MEG.0000000000000736
53
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2021; : 157 doi: 10.1007/978-3-319-68729-2_6
54
Neelakandan Ramya, Golepu Karthikeya, Sethu Prabhu Shankar. Association of Nonalcoholic Fatty Liver Disease with Coronary Artery Disease in Type 2 Diabetes Mellitus. Acta Medica International 2022; 9(1): 31 doi: 10.4103/amit.amit_25_22
55
Gyongyi Szabo, Jan Petrasek. Inflammasome activation and function in liver disease. Nature Reviews Gastroenterology & Hepatology 2015; 12(7): 387 doi: 10.1038/nrgastro.2015.94
56
Valerio Nobili, Anna Alisi, Kimberly P. Newton, Jeffrey B. Schwimmer. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1798 doi: 10.1053/j.gastro.2016.03.009
57
Yajie Chen, Yang Wang, Ziqiang Cui, Wenpeng Liu, Baowang Liu, Qiang Zeng, Xin Zhao, Jian Dou, Jinglin Cao. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1154837
58
A D Shah, N R Kandula, F Lin, M A Allison, J Carr, D Herrington, K Liu, A M Kanaya. Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies. International Journal of Obesity 2016; 40(4): 639 doi: 10.1038/ijo.2015.219
59
Danijela Ristic-Medic, Marijana Kovacic, Marija Takic, Aleksandra Arsic, Snjezana Petrovic, Marija Paunovic, Maja Jovicic, Vesna Vucic. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease. Nutrients 2020; 13(1): 15 doi: 10.3390/nu13010015
60
Wareed Alenaini, James R. C. Parkinson, John P. McCarthy, Anthony P. Goldstone, Henry R. Wilman, Rajarshi Banerjee, Hanieh Yaghootkar, Jimmy D. Bell, E. Louise Thomas. Ethnic Differences in Body Fat Deposition and Liver Fat Content in Two UK‐Based Cohorts. Obesity 2020; 28(11): 2142 doi: 10.1002/oby.22948
61
Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation. Food Science & Nutrition 2023; 11(12): 7485 doi: 10.1002/fsn3.3713
62
Afagh Garjani, Abdolrasoul Safaeiyan, Manouchehr Khoshbaten. Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2015; 15(1) doi: 10.5812/hepatmon.24449
63
Julia Uhanova, Gerald Minuk, Federico Lopez Ficher, Natasha Chandok. Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/6420408
64
Donna M. Conlon, Siri Kanakala, Tess Cherlin, Yi-An Ko, Cecilia Vitali, Sharavana Gurunathan, Rasika Venkatesh, Jakob Woerner, Lindsay A. Guare, Penn Medicine Biobank, Anurag Verma, Shefali S. Verma, Marie A. Guerraty. Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling. Genes 2024; 15(8): 1098 doi: 10.3390/genes15081098
65
Anthony R. Mawson. Understanding health disparities affecting people of West Central African descent in the United States: An evolutionary perspective. Evolutionary Applications 2023; 16(5): 963 doi: 10.1111/eva.13549
66
Kiyoshi Ichihara, Yesim Ozarda, Julian H Barth, George Klee, Yoshihisa Shimizu, Liangyu Xia, Mariza Hoffmann, Swarup Shah, Tandi Matsha, Janette Wassung, Francois Smit, Anna Ruzhanskaya, Joely Straseski, Daniel N Bustos, Shogo Kimura, Aki Takahashi. A global multicenter study on reference values: 2. Exploration of sources of variation across the countries. Clinica Chimica Acta 2017; 467: 83 doi: 10.1016/j.cca.2016.09.015
67
A. Vusirikala, T. Thomas, N. Bhala, A. A. Tahrani, G. N. Thomas, K. Nirantharakumar. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN). BMC Endocrine Disorders 2020; 20(1) doi: 10.1186/s12902-020-00582-9
68
Magda Shaheen, Katrina M. Schrode, Deyu Pan, Dulcie Kermah, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia M. Najjar, Theodore C. Friedman. Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.795421
69
Madlen Hempel, Annika Schmitz, Sandra Winkler, Ozlem Kucukoglu, Sandra Brückner, Carien Niessen, Bruno Christ. Pathological implications of cadherin zonation in mouse liver. Cellular and Molecular Life Sciences 2015; 72(13): 2599 doi: 10.1007/s00018-015-1861-y
70
Nico Gandha, Larisa Paramitha Wibawa, Tjut Nurul Alam Jacoeb, Andri Sanityoso Sulaiman. <p>Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter</p>. Psoriasis: Targets and Therapy 2020; : 39 doi: 10.2147/PTT.S272286
71
Yoosoo Chang, Hyun-Suk Jung, Juhee Cho, Yiyi Zhang, Kyung Eun Yun, Mariana Lazo, Roberto Pastor-Barriuso, Jiin Ahn, Chan-Won Kim, Sanjay Rampal, Miguel Cainzos-Achirica, Di Zhao, Eun Cheol Chung, Hocheol Shin, Eliseo Guallar, Seungho Ryu. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology 2016; 111(8): 1133 doi: 10.1038/ajg.2016.178
72
Abdel-Rauf Zeina, Limor Goldenberg, Alicia Nachtigal, Rabea Hasadia, Walid Saliba. Association between nephrolithiasis and fatty liver detected on non-enhanced CT for clinically suspected renal colic. Clinical Imaging 2017; 43: 148 doi: 10.1016/j.clinimag.2017.03.011
73
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update. 2019;  doi: 10.5772/intechopen.85780
74
S. E. Evstifeeva, S. A. Shalnova, V. A. Kutsenko, E. V. Yarovaya, Yu. A. Balanova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, S. A. Maksimov, N. S. Karamnova, A. G. Soplenkova, E. M. Filichkina, I. A. Viktorova, N. N. Prishchepa, A. N. Redko, S. S. Yakushin, O. M Drapkina. Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data). Cardiovascular Therapy and Prevention 2022; 21(9): 3356 doi: 10.15829/1728-8800-2022-3356
75
María Vanessa Bullón Vela, Itziar Abete , María de los Ángeles Zulet , Josep A. Tur , Xavier Pintó, Emili Corbella, Miguel Ángel Martínez González, Dolores Corella, Manuel Macías , Francisco Tinahones, Montserrat Fitó, Ramón Estruch, Emilio Ros, Jordi Salas Salvadó, Lidia Daimiel, J. Alfredo Martínez . Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome. Revista Española de Enfermedades Digestivas 2019; 112 doi: 10.17235/reed.2019.6031/2018
76
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02393-9
77
Austin Morrell, Brian P. Tripet, Brian J. Eilers, Megan Tegman, Damon Thompson, Valérie Copié, Jason L. Burkhead. Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models. The Journal of Nutritional Biochemistry 2020; 78: 108316 doi: 10.1016/j.jnutbio.2019.108316
78
Mohammad Safarian, Sepideh Mohammadpour, Mojtaba Shafiee, Azita Ganji, Anvar Soleimani, Mohsen Nematy, Ali Bahari. Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 989 doi: 10.1016/j.dsx.2019.01.005
79
Parita Patel, Charles Muller, Sonali Paul. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. World Journal of Hepatology 2020; 12(8): 506-518 doi: 10.4254/wjh.v12.i8.506
80
Alexis Mast, Armando Peña, Charlotte A. Bolch, Gabriel Shaibi, Kiley B. Vander Wyst. Sex differences in response to lifestyle intervention among children and adolescents: Systematic review and meta‐analysis. Obesity 2023; 31(3): 665 doi: 10.1002/oby.23663
81
Cheng Zhang, Mengnan Shi, Woonghee Kim, Muhammad Arif, Martina Klevstig, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Özlem Özdemir Tozlu, Ahmet Hacımuftuoglu, Serkan Yıldırım, Jihad Sebhaoui, Shazia Iqbal, Yongjun Wei, Xiaojing Shi, Jens Nielsen, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu. Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning. eBioMedicine 2022; 83: 104214 doi: 10.1016/j.ebiom.2022.104214
82
Ahmad Anouti, Karim Seif El Dahan, Nicole E. Rich, Jeremy Louissaint, William M. Lee, Sarah R. Lieber, Juan Pablo Arab, Bill Y. Zhang, Mausam J. Patel, Chanattha Thimphittaya, Luis Antonio Díaz, Dyanna L. Gregory, Julia Kozlitina, Lisa B. VanWagner, Andrea C. King, Mack C. Mitchell, Amit G. Singal, Thomas G. Cotter. Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis. Hepatology Communications 2024; 8(4) doi: 10.1097/HC9.0000000000000409
83
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
84
Mohamed Saleh, Joon Young Kim, Christine March, Nour Gebara, Silva Arslanian. Youth prediabetes and type 2 diabetes: Risk factors and prevalence of dysglycaemia. Pediatric Obesity 2022; 17(1) doi: 10.1111/ijpo.12841
85
Dina S. Ata, Mohy A.E. Awad, Manal A.E. Eid, Khaled I. ElShafey, Ola A. Taha. PNPLA3/adiponutrin I148M gene variant in nonalcoholic fatty liver disease in Egyptian children and adolescents. Alexandria Journal of Pediatrics 2021; 34(3): 203 doi: 10.4103/1687-9945.337830
86
Su-Min Jeong, Han Rim Lee, Wooyoung Jang, Dahye Kim, Jung Eun Yoo, Keun Hye Jeon, Sang-Man Jin, Kyungdo Han, Dong Wook Shin. Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease. Parkinsonism & Related Disorders 2021; 93: 19 doi: 10.1016/j.parkreldis.2021.10.030
87
Yanbin Dong. Alanine Aminotransferase levels are Associated with Cardiometabolic Risk Markers in Hispanic/Latino Farmworkers. Journal of Environment and Health Science 2018; 4(1): 20 doi: 10.15436/2378-6841.18.1561
88
Muhammad Izzad Johari, Khairiah Yusoff, Juhara Haron, Chandran Nadarajan, Khairun Nisah Ibrahim, Mung Seong Wong, Muhammad Ilham Abdul Hafidz, Bee Eng Chua, Nurhazwani Hamid, Wan Nor Arifin, Zheng Feei Ma, Yeong Yeh Lee. A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47763-8
89
I. P. Kalafati, M. Dimitriou, D. Borsa, J. Vlachogiannakos, K. Revenas, A. Kokkinos, S. D. Ladas, G. V. Dedoussis. Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case–control study. European Journal of Nutrition 2019; 58(4): 1463 doi: 10.1007/s00394-018-1675-4
90
Joo Hee Kwak, Dae Won Jun, Seung Min Lee, Yong Kyun Cho, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. Clinical Nutrition 2018; 37(5): 1550 doi: 10.1016/j.clnu.2017.08.018
91
Ueamporn Summart, Bandit Thinkhamrop, Nittaya Chamadol, Narong Khuntikeo, Metha Songthamwat, Christina Sunyoung Kim. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Research 2017; 6: 1630 doi: 10.12688/f1000research.12417.1
92
Sarah E. Messiah, Denise C. Vidot, Jordan Baeker Bispo, Kristopher L. Arheart, Zhamak Khorgami, Nestor De La Cruz-Muñoz. Ethnic and Gender Differences in the Prevalence of Nonalcoholic Steatohepatitis Among Bariatric Surgery Patients. Bariatric Surgical Practice and Patient Care 2016; 11(4): 153 doi: 10.1089/bari.2016.0018
93
Rupak Desai, Ali Tariq Alvi, Advait Vasavada, Yashwitha Sai Pulakurthi, Bhavin Patel, Adil Sarvar Mohammed, Shreyans Doshi, Ikechukwu Ogbu. Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019). World Journal of Cardiology 2024; 16(3): 137-148 doi: 10.4330/wjc.v16.i3.137
94
Cheng-Tse Wu, Ta-Wei Chu, Jyh-Shing Roger Jang. Current-Visit and Next-Visit Prediction for Fatty Liver Disease With a Large-Scale Dataset: Model Development and Performance Comparison. JMIR Medical Informatics 2021; 9(8): e26398 doi: 10.2196/26398
95
Mona H. Ismail, Reem Al Argan, Yasir Elamin, Murtaga Makki, Lameya Alsheekh, Jaber Alelyani, Zahra Hadhiah, Zahrah Aljidhr, Nazih Alkhatam, Hind Alfaddagh, Alanoud Alanazi, Shaya Alqahtani. Automated Fibrosis-4 Index: Simplifying Non-Alcoholic Fatty Liver Disease for Diabetologists. Medicina 2024; 60(8): 1278 doi: 10.3390/medicina60081278
96
Tagreed A. Mazi, Kamil Borkowski, Oliver Fiehn, Christopher L. Bowlus, Souvik Sarkar, Karen Matsukuma, Mohamed R. Ali, Dorothy A. Kieffer, Yu-Jui Y. Wan, Kimber L. Stanhope, Peter J. Havel, John W. Newman, Valentina Medici. Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis. Metabolites 2022; 12(2): 192 doi: 10.3390/metabo12020192
97
Zhilan Xie, Ruxianguli Aimuzi, Mingyu Si, Yimin Qu, Yu Jiang. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1133194
98
Monica M. Betancourt-Garcia, Armando Arguelles, Jorge Montes, Ambrosio Hernandez, Manish Singh, R. Armour Forse. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children. Obesity Surgery 2017; 27(1): 236 doi: 10.1007/s11695-016-2440-5
99
Isabel Song, Elizabeth W. Thompson, Anurag Verma, Matthew T. MacLean, Jeffrey Duda, Ameena Elahi, Richard Tran, Pavan Raghupathy, Sophia Swago, Mohamad Hazim, Abhijit Bhattaru, Carolin Schneider, Marijana Vujkovic, Drew A. Torigian, Charles E. Kahn, James C. Gee, Arijitt Borthakur, Colleen M. Kripke, Christopher C. Carson, Rotonya Carr, Qasim Jehangir, Yi-An Ko, Harold Litt, Mark Rosen, David A. Mankoff, Mitchell D. Schnall, Haochang Shou, Julio Chirinos, Scott M. Damrauer, Marina Serper, Jinbo Chen, Daniel J. Rader, Marylyn D. Ritchie, JoEllen Weaver, Nawar Naseer, Afiya Poindexter, Khadijah Hu-Sain, Meghan Livingstone, Fred Vadivieso, Stephanie DerOhannessian, Teo Tran, Julia Stephanowski, Monica Zielinski, Ned Haubein, Joseph Dunn, Anurag Verma, Colleen M. Kripke, Marjorie Risman, Renae Judy, Shefali S. Verma, Yuki Bradford, Scott Dudek, Theodore Drivas, Walter R. T. Witschey, Hersh Sagreiya. Clinical correlates of CT imaging-derived phenotypes among lean and overweight patients with hepatic steatosis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-49470-x
100
Christy Boling Turer, Biff F. Palmer. Tools for Successful Weight Management in Primary Care. The American Journal of the Medical Sciences 2015; 350(6): 485 doi: 10.1097/MAJ.0000000000000530
101
Gaetano Scotto, Vincenzina Fazio. CHANGING TRENDS IN AETIOLOGY OF LIVER DISEASES IN IMMIGRANTS IN SOUTHERN ITALY: FATTY LIVER, AN OBSERVATIONAL RETROSPECTIVE STUDY. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 65 doi: 10.36106/ijsr/5830850
102
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
103
Kaia C. Miller, Bridget Geyer, Anastasia-Stefania Alexopoulos, Cynthia A. Moylan, Neha Pagidipati. Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review. Digestive Diseases and Sciences 2024;  doi: 10.1007/s10620-024-08722-0
104
Marija Branković, Igor Jovanović, Marija Dukić, Tijana Radonjić, Svetlana Oprić, Slobodan Klašnja, Marija Zdravković. Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(9): 5146 doi: 10.3390/ijms23095146
105
Maximilian Neumann, Elisabeth Meier, Lisa Rein-Fischboeck, Sabrina Krautbauer, Kristina Eisinger, Charalampos Aslanidis, Rebekka Pohl, Thomas Weiss, Christa Buechler. Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female Individuals. International Journal of Molecular Sciences 2016; 17(8): 1335 doi: 10.3390/ijms17081335
106
Oriol Juanola, Sebastián Martínez-López, Rubén Francés, Isabel Gómez-Hurtado. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. International Journal of Environmental Research and Public Health 2021; 18(10): 5227 doi: 10.3390/ijerph18105227
107
A. Katrina Loomis, Shaum Kabadi, David Preiss, Craig Hyde, Vinicius Bonato, Matthew St. Louis, Jigar Desai, Jason M. R. Gill, Paul Welsh, Dawn Waterworth, Naveed Sattar. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. The Journal of Clinical Endocrinology & Metabolism 2016; 101(3): 945 doi: 10.1210/jc.2015-3444
108
Alexandra Kautzky-Willer, Jürgen Harreiter, Giovanni Pacini. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocrine Reviews 2016; 37(3): 278 doi: 10.1210/er.2015-1137
109
Kyungsun Han, Ojin Kwon, Hyo-ju Park, So-Young Jung, Changsop Yang, Chang-Gue Son. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-4068-y
110
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
111
Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso. Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease. Exploration of Medicine 2020; 1(2): 51 doi: 10.37349/emed.2020.00005
112
Floriane Rudwill, Audrey Bergouignan, Caroline Gastebois, Guillemette Gauquelin‐Koch, Etienne Lefai, Stéphane Blanc, Chantal Simon. Effect of enforced physical inactivity induced by 60‐day of bed rest on hepatic markers of NAFLD in healthy normal‐weight women. Liver International 2015; 35(6): 1700 doi: 10.1111/liv.12743
113
Naomi Fearon, Dimitri Pournaras. Obesity, Bariatric and Metabolic Surgery. 2022; : 1 doi: 10.1007/978-3-030-54064-7_107-1
114
L. M. Goff. Ethnicity and Type 2 diabetes in the UK. Diabetic Medicine 2019; 36(8): 927 doi: 10.1111/dme.13895
115
Harini Sarathy, Gabriela Henriquez, Matthew K. Abramowitz, Holly Kramer, Sylvia E. Rosas, Tanya Johns, Juhi Kumar, Amy Skversky, Frederick Kaskel, Michal L. Melamed, Florian Kronenberg. Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010. PLOS ONE 2016; 11(5): e0153588 doi: 10.1371/journal.pone.0153588
116
Debbie S Thompson, Ingrid A Tennant, Deanne P Soares, Clive Osmond, Chris D Byrne, Terrence E Forrester, Michael S Boyne. Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics. Journal of the Endocrine Society 2019; 3(11): 2051 doi: 10.1210/js.2019-00138
117
Bahareh Amirkalali, Masoud Reza Sohrabi, Parvaneh Rahimi-Moghaddam, Ali Esrafily, Ali Gholami, Payam Hosseinzadeh, Hossein Keyvani, Farzad Shidfar, Farhad Zamani. The Association of Nicotinamide Phosphoribosyltransferase Polymorphism with Markers of Hepatic Injury and De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.13570
118
Gregor Lorbek, Žiga Urlep, Damjana Rozman. Pharmacogenomic and Personalized Approaches to Tackle Nonalcoholic Fatty Liver Disease. Pharmacogenomics 2016; 17(11): 1273 doi: 10.2217/pgs-2016-0047
119
Eun Na Han, Eun Sun Cheong, Jeong In Lee, Min Chul Kim, Christopher D. Byrne, Ki-Chul Sung. Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study. Clinical Hypertension 2015; 21(1) doi: 10.1186/s40885-015-0032-7
120
Pegah Golabi, Vasily Isakov, Zobair M. Younossi. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness. Clinics in Liver Disease 2023; 27(2): 173 doi: 10.1016/j.cld.2023.01.001
121
Nadine Al‐Naamani, Jessica K. Paulus, Kari E. Roberts, Michael W. Pauciulo, Katie Lutz, William C. Nichols, Steven M. Kawut. Racial and ethnic differences in pulmonary arterial hypertension. Pulmonary Circulation 2017; 7(4): 793 doi: 10.1177/2045893217732213
122
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman, Peter P. Toth. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2022; 42(6) doi: 10.1161/ATV.0000000000000153
123
Karthickeyan Chella Krishnan, Margarete Mehrabian, Aldons J. Lusis. Sex differences in metabolism and cardiometabolic disorders. Current Opinion in Lipidology 2018; 29(5): 404 doi: 10.1097/MOL.0000000000000536
124
Charles L. Phillips, Tran T. Le, Seth T. Lirette, Bradley A. Welch, Sarah C. Glover, Adam Dungey, Kenneth D. Vick, Bernadette E. Grayson, Rasheed Ahmad. Immune marker reductions in black and white Americans following sleeve gastrectomy in the short-term phase of surgical weight loss. PLOS ONE 2023; 18(7): e0288868 doi: 10.1371/journal.pone.0288868
125
Qingming Dong, Michael S. Kuefner, Xiong Deng, Dave Bridges, Edwards A. Park, Marshall B. Elam, Rajendra Raghow. Sex-specific differences in hepatic steatosis in obese spontaneously hypertensive (SHROB) rats. Biology of Sex Differences 2018; 9(1) doi: 10.1186/s13293-018-0202-x
126
Jianzhu Luo, Walter H. Watson, Tyler C. Gripshover, Zayna Qaissi, Banrida Wahlang. Sex-specific effects of acute chlordane exposure in the context of steatotic liver disease, energy metabolism and endocrine disruption. Food and Chemical Toxicology 2023; 180: 114024 doi: 10.1016/j.fct.2023.114024
127
Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, Camelia Protopopescu, Isabelle Poizot-Martin, Marie Libérée Nishimwe, David Zucman, Laure Esterle, Eric Billaud, Hugues Aumaitre, Olivier Bouchaud, David Rey, Lionel Piroth, Dominique Salmon-Ceron, Linda Wittkop, Philippe Sogni, Maria Patrizia Carrieri, Lawrence Serfaty, Fabienne Marcellin. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH). Expert Review of Anti-infective Therapy 2021; 19(9): 1147 doi: 10.1080/14787210.2021.1884545
128
Janet M. Wojcicki, David Rehkopf, Elissa Epel, Philip Rosenthal. Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999–2002. International Journal of Hepatology 2017; 2017: 1 doi: 10.1155/2017/8435178
129
Kaushalya Kulathunga, Arata Wakimoto, Yukiko Hiraishi, Manoj Kumar Yadav, Kyle Gentleman, Eiji Warabi, Tomoki Sakasai, Yoshihiro Miwa, Seiya Mizuno, Satoru Takahashi, Michito Hamada. Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00501-5
130
Prajakta Ankur Vagurmekar, Agnelo Menino Ferreira, Frederick Satiro Vaz, Hemangini Kishore Shah, Amit Savio Dias, Manojkumar S. Kulkarni. Prevalence of non-alcoholic fatty liver disease (NAFLD) among adults in urban Goa. The National Medical Journal of India 2024; 36: 401 doi: 10.25259/NMJI_37_2022
131
Varanasi Yugandar Bhargav, Mayank Jain, Tom Alen, Chandan Kumar Kedarisetty, Preetam Arthur, Mu Karthikeyan, Thamarai S. Selvan, Jayanthi Venkataraman. Clusters and Components of Metabolic Syndrome (MeS) as a Predictor for Fatty Liver. Journal of Diabetology 2021; 12(4): 434 doi: 10.4103/jod.jod_17_21
132
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
133
Fangzhi Yue, Ke Xia, Lin Wei, Lin Xing, Shanyu Wu, Ying Shi, Sin Man Lam, Guanghou Shui, Xingwei Xiang, Ryan Russell, Dongmei Zhang. Effects of constant light exposure on sphingolipidomics and progression of NASH in high‐fat‐fed rats. Journal of Gastroenterology and Hepatology 2020; 35(11): 1978 doi: 10.1111/jgh.15005
134
Ghada M. A. Ajabnoor, Suhad M. Bahijri, Sumia Mohammad Enani, Lubna Alsheikh, Maimoona Ahmed, Amani Alhozali, Khalid Al-Shali, Basmah Medhat Eldakhakhny, Aliaa A. Alamoudi, Jawaher Al-Ahmadi, Anwar Borai, Alaa Salem Al-Mowallad, Jaakko Tuomilehto. Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia. Diseases 2023; 11(1): 10 doi: 10.3390/diseases11010010
135
Praveen Sharma, Ashish Kumar. Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(5): 825 doi: 10.1016/j.dsx.2020.06.013
136
Ke Liu, Shiyun Tang, Chenhao Liu, Jianli Ma, Xiyu Cao, Xiuli Yang, Yi Zhu, Ke Chen, Ya Liu, Chuantao Zhang, Yi Liu. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1337241
137
Hilmar K L&uuml;ckhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
138
Daryl Ramai, Antonio Facciorusso, Erika Vigandt, Bryan Schaf, Waleed Saadedeen, Aditya Chauhan, Sara di Nunzio, Aashni Shah, Luca Giacomelli, Rodolfo Sacco. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(12): 3401 doi: 10.3390/cells10123401
139
Lianna W. Wat, Charlotte Chao, Rachael Bartlett, Justin L. Buchanan, Jason W. Millington, Hui Ju Chih, Zahid S. Chowdhury, Puja Biswas, Vivian Huang, Leah J. Shin, Lin Chuan Wang, Marie-Pierre L. Gauthier, Maria C. Barone, Kristi L. Montooth, Michael A. Welte, Elizabeth J. Rideout, Bassem A. Hassan. A role for triglyceride lipase brummer in the regulation of sex differences in Drosophila fat storage and breakdown. PLOS Biology 2020; 18(1): e3000595 doi: 10.1371/journal.pbio.3000595
140
Rohini Mehta, Kianoush Jeiran, Aaron B. Koenig, Munkzhul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair Younossi. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). BMC Medical Genetics 2016; 17(1) doi: 10.1186/s12881-016-0324-0
141
Jennifer Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather L. Stevenson, Joseph B. McCormick, Susan P. Fisher-Hoch, Jianhua Zhang, P. Andrew Futreal, Laura Beretta. Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget 2018; 9(50): 29495 doi: 10.18632/oncotarget.25685
142
Olah Hakim, Riccardo C Bonadonna, Cynthia Mohandas, Zoya Billoo, Alexander Sunderland, Linda Boselli, K George M M Alberti, Janet L Peacock, A Margot Umpleby, Geoff Charles-Edwards, Stephanie A Amiel, Louise M Goff. Associations Between Pancreatic Lipids andβ-Cell Function in Black African and White European Men With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism 2019; 104(4): 1201 doi: 10.1210/jc.2018-01809
143
Gary Huang, Daniel F. Wallace, Elizabeth E. Powell, Tony Rahman, Paul J. Clark, V. Nathan Subramaniam. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. Biomedicines 2023; 11(10): 2809 doi: 10.3390/biomedicines11102809
144
Yafeng Wang, Yurui Jiao, Jing Nie, Adrienne O’Neil, Wentao Huang, Lei Zhang, Jiafei Han, Hao Liu, Yikun Zhu, Chuanhua Yu, Mark Woodward. Sex differences in the association between marital status and the risk of cardiovascular, cancer, and all-cause mortality: a systematic review and meta-analysis of 7,881,040 individuals. Global Health Research and Policy 2020; 5(1) doi: 10.1186/s41256-020-00133-8
145
Leanne Hodson, Fredrik Rosqvist, Siôn A Parry. The influence of dietary fatty acids on liver fat content and metabolism. Proceedings of the Nutrition Society 2020; 79(1): 30 doi: 10.1017/S0029665119000569
146
Kyung Eun Yun, Ga Eun Nam, Jisun Lim, Hye Soon Park, Yoosoo Chang, Hyun-Suk Jung, Chan-Won Kim, Byung-Joon Ko, Eun Chul Chung, Hocheol Shin, Seungho Ryu, Giovanni Targher. Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study. PLOS ONE 2016; 11(7): e0158710 doi: 10.1371/journal.pone.0158710
147
Shira Zelber-Sagi, Reut Zur, Tamar Thurm, Alex Goldstein, Ofir Ben-Assuli, Gabriel Chodick, Oren Shibolet. Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population. Annals of Hepatology 2019; 18(4): 578 doi: 10.1016/j.aohep.2019.03.006
148
Mohammad Moradzad, Mohammad Abdi, Farshad Sheikh Esmaeili, Dana Ghaderi, Khaled Rahmani, Mohammad Raman Moloudi, Zakaria Vahabzadeh. Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease. Molecular Biology Reports 2022; 49(7): 5927 doi: 10.1007/s11033-022-07375-4
149
Ana Francisca Soares, Jonathan Paz‐Montoya, Hongxia Lei, Marc Moniatte, Rolf Gruetter. Sexual dimorphism in hepatic lipids is associated with the evolution of metabolic status in mice. NMR in Biomedicine 2017; 30(10) doi: 10.1002/nbm.3761
150
Elhamy R. Heba, Ajinkya Desai, Kevin A. Zand, Gavin Hamilton, Tanya Wolfson, Alexandra N. Schlein, Anthony Gamst, Rohit Loomba, Claude B. Sirlin, Michael S. Middleton. Accuracy and the effect of possible subject‐based confounders of magnitude‐based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. Journal of Magnetic Resonance Imaging 2016; 43(2): 398 doi: 10.1002/jmri.25006
151
Rodica Talmaci. miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventions. Dietetician.ro 2023; 3(3): 18 doi: 10.26416/Diet.3.3.2023.8754
152
Yula Kaminsky-Kolesnikov, Einat Rauchbach, Diana Abu-Halaka, Michal Hahn, Carmen García-Ruiz, Jose C. Fernandez-Checa, Zecharia Madar, Oren Tirosh. Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5393761
153
Benito de Celis Alonso, Elizabeth Shumbayawonda, Cayden Beyer, Silvia Hidalgo-Tobon, Briseida López-Martínez, Pilar Dies-Suarez, Miguel Klunder-Klunder, América Liliana Miranda-Lora, Eduardo Barragán Pérez, Helena Thomaides-Brears, Rajarshi Banerjee, E. Louise Thomas, Jimmy D. Bell, Po-Wah So. Liver magnetic resonance imaging, non-alcoholic fatty liver disease and metabolic syndrome risk in pre-pubertal Mexican boys. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-77307-8
154
Gregory G. Martin, Danilo Landrock, Lawrence J. Dangott, Avery L. McIntosh, Ann B. Kier, Friedhelm Schroeder. Human Liver Fatty Acid Binding Protein‐1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System. Lipids 2018; 53(1): 27 doi: 10.1002/lipd.12008
155
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Digestive Diseases and Sciences 2016; 61(5): 1214 doi: 10.1007/s10620-016-4143-0
156
Jingyue Sun, Jiemin Fan, Tingting Li, Xiaoxue Yan, Yihong Jiang. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis via Modulation of Gut Microbiota and Bile Acid Metabolism in Rats. Journal of Agricultural and Food Chemistry 2022; 70(38): 12014 doi: 10.1021/acs.jafc.2c04817
157
Rotonya M. Carr, Amanke Oranu, Vandana Khungar. Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2016; 45(4): 639 doi: 10.1016/j.gtc.2016.07.003
158
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
159
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?. Current HIV/AIDS Reports 2018; 15(3): 212 doi: 10.1007/s11904-018-0392-1
160
Kiley B. Vander Wyst, Micah L. Olson, Colleen S. Keller, Erica G. Soltero, Allison N. Williams, Armando Peña, Stephanie L. Ayers, Justin Jager, Gabriel Q. Shaibi. Sex as a moderator of body composition following a randomized controlled lifestyle intervention among Latino youth with obesity. Pediatric Obesity 2020; 15(6) doi: 10.1111/ijpo.12620
161
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
162
Anna E. Garcia, Nader Kasim, Robyn A. Tamboli, Raul S. Gonzalez, Joseph Antoun, Emily A. Eckert, Pamela A. Marks-Shulman, Julia Dunn, Julia Wattacheril, Taylor Wallen, Naji N. Abumrad, Charles Robb Flynn, Manlio Vinciguerra. Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease. PLOS ONE 2015; 10(11): e0142676 doi: 10.1371/journal.pone.0142676
163
Tao-Chun Peng, Tung-Wei Kao, Li-Wei Wu, Ying-Jen Chen, Yaw-Wen Chang, Chung-Ching Wang, Yu-Tzu Tsao, Wei-Liang Chen. Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study. Medicine 2015; 94(21): e907 doi: 10.1097/MD.0000000000000907
164
Sarah E. Elzinga, Masha G. Savelieff, Phillipe D. O'Brien, Faye E. Mendelson, John M. Hayes, Eva L. Feldman. Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model. Disease Models & Mechanisms 2021; 14(4) doi: 10.1242/dmm.048909
165
Stephanie M. Rutledge, Emily R. Soper, Ning Ma, Vikas Pejaver, Scott L. Friedman, Andrea D. Branch, Eimear E. Kenny, Gillian M. Belbin, Noura S. Abul-Husn. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries. Clinical Gastroenterology and Hepatology 2023; 21(10): 2578 doi: 10.1016/j.cgh.2022.12.025
166
Lisanne L. Blauw, Zhuang Li, Sander S. Rensen, Jan Willem M. Greve, Aswin Verhoeven, Rico J. Derks, Martin Giera, Yanan Wang, Patrick C.N. Rensen. Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP. Atherosclerosis 2018; 275: 149 doi: 10.1016/j.atherosclerosis.2018.06.004
167
Meredith A. J. Hullar, Isaac C. Jenkins, Timothy W. Randolph, Keith R. Curtis, Kristine R. Monroe, Thomas Ernst, John A. Shepherd, Daniel O. Stram, Iona Cheng, Bruce S. Kristal, Lynne R. Wilkens, Adrian Franke, Loic Le Marchand, Unhee Lim, Johanna W. Lampe. Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1965463
168
Sang R Lee, Young Ho Lee, Hyun Yang, Hye Won Lee, Geun-Shik Lee, Beum-Soo An, Eui-Bae Jeung, Bae-Keun Park, Eui-Ju Hong. Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause. Carcinogenesis 2019; 40(8): 1031 doi: 10.1093/carcin/bgz107
169
Nam-Hun Lee, Seok-Ju Jeong, Jing-Hua Wang, Yu-Jin Choi, Hyeon-Muk Oh, Jung-Hyo Cho, Yo-Chan Ahn, Chang-Gue Son. The Clinical Diagnosis-Based Nationwide Epidemiology of Metabolic Dysfunction-Associated Liver Disease in Korea. Journal of Clinical Medicine 2023; 12(24): 7634 doi: 10.3390/jcm12247634
170
Clarissa Elysia Fu, Margaret Teng, Daniel Tung, Vijay Ramadoss, Christen Ong, Benjamin Koh, Wen Hui Lim, Darren Jun Hao Tan, Jia Hong Koh, Benjamin Nah, Nicholas Syn, Nobuharu Tamaki, Mohammad Shadab Siddiqui, Karn Wijarnpreecha, George N. Ioannou, Atsushi Nakajima, Mazen Noureddin, Arun J. Sanyal, Cheng Han Ng, Mark Muthiah. Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals. Digestive Diseases and Sciences 2024; 69(9): 3195 doi: 10.1007/s10620-024-08540-4
171
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
172
Marie Lequoy, Elia Gigante, Jean-Pierre Couty, Christèle Desbois-Mouthon. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2019-0044
173
Jieun Moon, Eunji Kong, Jingu Lee, Jinjoo Jung, Eunha Kim, Seung Bum Park, Pilhan Kim. Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. Biomedical Optics Express 2020; 11(9): 5132 doi: 10.1364/BOE.395890
174
Michael Charlton, Ivy Tonnu-Mihara, Chia-Chen Teng, Ziqi Zhou, Feven Asefaha, Rakesh Luthra, Amy Articolo, Anthony Hoovler, Chioma Uzoigwe. Evaluating the burden of illness of metabolic dysfunction–associated steatohepatitis in a large managed care population: The ETHEREAL Study. Journal of Managed Care & Specialty Pharmacy 2024; : 1 doi: 10.18553/jmcp.2024.24106
175
Monica A. Konerman, Patrick Walden, Megan Joseph, Elizabeth A. Jackson, Anna S. Lok, Melvyn Rubenfire. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2019; 49(3): 296 doi: 10.1111/apt.15063
176
Ilaria Barchetta, Francesco Angelico, Maria Del Ben, Michele Di Martino, Flavia Agata Cimini, Laura Bertoccini, Licia Polimeni, Carlo Catalano, Antonio Fraioli, Riccardo Del Vescovo, Sergio Morini, Marco Giorgio Baroni, Maria Gisella Cavallo. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes. Clinical Science 2016; 130(19): 1753 doi: 10.1042/CS20160348
177
Louise M. Goff, Meera Ladwa, Olah Hakim, Oluwatoyosi Bello. Ethnic distinctions in the pathophysiology of type 2 diabetes: a focus on black African-Caribbean populations. Proceedings of the Nutrition Society 2020; 79(2): 184 doi: 10.1017/S0029665119001034
178
Jiahui Xu, Shu Ni, Yuming Wang, Mengfan Yan, Xueli Yang, Han Ge, Zizhuo Jia, Ze Yang, Anqi Shan, Huanyu Liu, Nai-jun Tang. Shift work and nonalcoholic fatty liver disease incidence among Chinese rail workers: a 4-year longitudinal cohort study. International Archives of Occupational and Environmental Health 2023; 96(1): 179 doi: 10.1007/s00420-022-01913-0
179
Dae Won Jun, Mindie H. Nguyen. Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease—one size does not fit all. Authors' reply. Alimentary Pharmacology & Therapeutics 2020; 51(6): 662 doi: 10.1111/apt.15651
180
Kayleigh M. Beaudry, Michaela C. Devries. Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism. Applied Physiology, Nutrition, and Metabolism 2019; 44(8): 805 doi: 10.1139/apnm-2018-0635
181
Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ming-Lung Yu. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. PLOS ONE 2021; 16(8): e0255535 doi: 10.1371/journal.pone.0255535
182
Dolores B. Njoku, Joel D. Schilling, Brian N. Finck. Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver–heart crosstalk. Current Opinion in Lipidology 2022; 33(5): 295 doi: 10.1097/MOL.0000000000000845
183
Monica A. Konerman, Jacob C. Jones, Stephen A. Harrison. Pharmacotherapy for NASH: Current and emerging. Journal of Hepatology 2018; 68(2): 362 doi: 10.1016/j.jhep.2017.10.015
184
Narges Ashraf Ganjooei, Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Majid Khadem-Rezaiyan, Željko Reiner, Mona Alidadi, Alexander M. Markin, Amirhossein Sahebkar. The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.682352
185
Reza Ranjbar, Mojtaba Shafiee, AmirReza Hesari, Gordon A. Ferns, Faezeh Ghasemi, Amir Avan. The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases. Journal of Cellular Physiology 2019; 234(3): 2277 doi: 10.1002/jcp.27205
186
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2020; : 1 doi: 10.1007/978-3-319-66362-3_6-1
187
Maureen P. Kohi. Gender-Related Differences in Hepatocellular Carcinoma: Does Sex Matter?. Journal of Vascular and Interventional Radiology 2016; 27(9): 1338 doi: 10.1016/j.jvir.2016.06.035
188
Heather B Clair, Christina M Pinkston, Shesh N Rai, Marian Pavuk, Nina D Dutton, Guy N Brock, Russell A Prough, Keith Cameron Falkner, Craig J McClain, Matthew C Cave. Liver Disease in a Residential Cohort With Elevated Polychlorinated Biphenyl Exposures. Toxicological Sciences 2018; 164(1): 39 doi: 10.1093/toxsci/kfy076
189
Elizabeth Shumbayawonda, Cayden Beyer, Benito de Celis Alonso, Silvia Hidalgo-Tobon, Briceida López-Martínez, Miguel Klunder-Klunder, América Liliana Miranda-Lora, E. Louise Thomas, Jimmy D. Bell, David J. Breen, Kamil Janowski, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha, Po-Wah So. Reference Range of Quantitative MRI Metrics Corrected T1 and Liver Fat Content in Children and Young Adults: Pooled Participant Analysis. Children 2024; 11(10): 1230 doi: 10.3390/children11101230
190
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
191
Karthickeyan Chella Krishnan, Raquel R. Floyd, Simon Sabir, Dulshan W. Jayasekera, Paola V. Leon-Mimila, Anthony E. Jones, Angel A. Cortez, Varun Shravah, Miklós Péterfy, Linsey Stiles, Samuel Canizales-Quinteros, Ajit S. Divakaruni, Adriana Huertas-Vazquez, Aldons J. Lusis. Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(2): 389 doi: 10.1016/j.jcmgh.2020.09.004
192
Aderonke A. Akinkugbe, A. Sidney Barritt, Jianwen Cai, Steven Offenbacher, Bharat Thyagarajan, Tasneem Khambaty, Richard Singer, Eric Kallwitz, Gerardo Heiss, Gary D. Slade. Periodontitis and prevalence of elevated aminotransferases in the Hispanic Community Health Study/Study of Latinos. Journal of Periodontology 2018; 89(8): 949 doi: 10.1002/JPER.17-0579
193
Jenny C. Link, Karen Reue. Genetic Basis for Sex Differences in Obesity and Lipid Metabolism. Annual Review of Nutrition 2017; 37(1): 225 doi: 10.1146/annurev-nutr-071816-064827
194
Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M. Younossi. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis. Medicine 2018; 97(31): e11518 doi: 10.1097/MD.0000000000011518
195
Jessica Musto, Erin K. Spengler, Margarita N. German. Sexual Dimorphisms in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2021; 20(4): 97 doi: 10.1007/s11901-021-00568-8
196
Donna M. Conlon, Francine K. Welty, Gissette Reyes-Soffer, Jaume Amengual. Sex-Specific Differences in Lipoprotein Production and Clearance. Arteriosclerosis, Thrombosis, and Vascular Biology 2023; 43(9): 1617 doi: 10.1161/ATVBAHA.122.318247
197
Shima A. Dowla, Amy M. Goss, Ambika P. Ashraf. Global Perspectives on Childhood Obesity. 2019; : 255 doi: 10.1016/B978-0-12-812840-4.00020-7
198
Carmen de la Rocha, J. Eduardo Pérez-Mojica, Silvia Zenteno-De León, Braulio Cervantes-Paz, Fabiola E. Tristán-Flores, Dalia Rodríguez-Ríos, Jorge Molina-Torres, Enrique Ramírez-Chávez, Yolanda Alvarado-Caudillo, F. Javier Carmona, Manel Esteller, Rosaura Hernández-Rivas, Katarzyna Wrobel, Kazimierz Wrobel, Silvio Zaina, Gertrud Lund. Associations between whole peripheral blood fatty acids and DNA methylation in humans. Scientific Reports 2016; 6(1) doi: 10.1038/srep25867
199
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
200
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021;  doi: 10.7759/cureus.20776
201
Zhao Li, Lan Lan, Yujia Zhou, Ruoxing Li, Kenneth D. Chavin, Hua Xu, Liang Li, David J.H. Shih, W. Jim Zheng. Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health records. Journal of Biomedical Informatics 2024; 152: 104626 doi: 10.1016/j.jbi.2024.104626
202
Veronica Wendy Setiawan, Daniel O. Stram, Jacqueline Porcel, Shelly C. Lu, Loïc Le Marchand, Mazen Noureddin. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology 2016; 64(6): 1969 doi: 10.1002/hep.28677
203
Young-Gyun Seo, Stergios A. Polyzos, Kyung-Hee Park, Christos S. Mantzoros. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population. Clinical Gastroenterology and Hepatology 2023; 21(13): 3322 doi: 10.1016/j.cgh.2023.04.026
204
Kamna Tiwari, Archana Gupta, Pankaj Kumar Gupta. “CROSS- SECTIONAL STUDY OF NON ALCOHOLIC FATTY LIVER DISEASE AND IT'S ASSOCIATION WITH CENTRAL OBESITY, DYSLIPIDEMIA AND IMPAIRED GLUCOSE TOLERANCE.”. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2022; : 54 doi: 10.36106/ijsr/4607252
205
Bel M. Galmés-Pascual, Melanie Raquel Martínez-Cignoni, Andrea Morán-Costoya, Marco Bauza-Thorbrügge, Miquel Sbert-Roig, Adamo Valle, Ana M. Proenza, Isabel Lladó, Magdalena Gianotti. 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free Radical Biology and Medicine 2020; 150: 148 doi: 10.1016/j.freeradbiomed.2020.02.016
206
Natalia Salinas Parra, Michelle Schafer, Heather M. Ross, John Bruckbauer, Brian Yan, Sarah L. Chen, Adnan Khan, Danielle M. Tholey, Dina Halegoua-DeMarzio. Prevalence of post-liver transplant complications and NASH-related cirrhosis in postmenopausal women. Annals of Hepatology 2024; 29(1): 101157 doi: 10.1016/j.aohep.2023.101157
207
Akash Batta, Juniali Hatwal. Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!. World Journal of Cardiology 2024; 16(7): 380-384 doi: 10.4330/wjc.v16.i7.380
208
Jiajing Xin, Saihong Yan, Xiangsheng Hong, Huan Zhang, Jinmiao Zha. Environmentally relevant concentrations of clozapine induced lipotoxicity and gut microbiota dysbiosis in Chinese rare minnow (Gobiocypris rarus). Environmental Pollution 2021; 286: 117298 doi: 10.1016/j.envpol.2021.117298
209
Qian‐Nan Ren, Hong Zhang, Chao‐Yue Sun, Yu‐Feng Zhou, Xue‐Feng Yang, Jian‐Wu Long, Xiao‐Xing Li, Shi‐Juan Mai, Mei‐Yin Zhang, Hui‐Zhong Zhang, Hai‐Qiang Mai, Min‐Shan Chen, X.F. Steven Zheng, Hui‐Yun Wang. Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis. Hepatology 2022; 75(5): 1123 doi: 10.1002/hep.32120
210
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?. Cancer 2020; 126(13): 3151 doi: 10.1002/cncr.32794
211
FC Smit, K Ichihara, J George, E Blanco-Blanco, M Hoffmann, RT Erasmus, TE Matsha-Erasmus. Establishment of reference intervals of biochemical analytes for South African adults: a study conducted as part of the IFCC global multicentre study on reference values. The Journal of Medical Laboratory Science and Technology of South Africa 2021; 3(1): 8 doi: 10.36303/JMLSTSA.2021.3.1.64
212
Siôn A Parry, Leanne Hodson. Influence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism. Journal of Investigative Medicine 2017; 65(8): 1102 doi: 10.1136/jim-2017-000524
213
Qian WANG, Dongmei Zheng, Jia Liu, Li FANG, Qiu Li. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0932-0
214
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 523 doi: 10.1002/9781119211419.ch35
215
Amanda Tamar Schneier, Caitlin Colleen Citti, Douglas T Dieterich. Management and diagnosis of fatty liver disease. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 671 doi: 10.1586/17474124.2015.1003209
216
Jie Yu, Xuesong Yang, Ya Luo, Xuefeng Yang, Mengxue Yang, Jin Yang, Jie Zhou, Feng Gao, Liting He, Jie Xu, Jonathan M. Peterson. Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats. PLOS ONE 2017; 12(7): e0180218 doi: 10.1371/journal.pone.0180218
217
E Vassilatou, D A Vassiliadi, K Salambasis, H Lazaridou, N Koutsomitopoulos, N Kelekis, D Kassanos, D Hadjidakis, G Dimitriadis. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease. European Journal of Endocrinology 2015; 173(6): 739 doi: 10.1530/EJE-15-0567
218
Andy Liu, Artin Galoosian, Dharmesh Kaswala, Andrew A. Li, Chiranjeevi Gadiparthi, George Cholankeril, Donghee Kim, Aijaz Ahmed. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00010
219
Dan Eisenberg, Katherine D. Arnow, Nicolas B. Barreto, Kristen Davis, Sherri L. LaVela, Susan M. Frayne, Andrea L. Nevedal, Justina Wu, Alex H. S. Harris. Interaction between increasing body mass index and spinal cord injury to the probability of developing a diagnosis of nonalcoholic fatty liver disease. Obesity Science & Practice 2023; 9(3): 253 doi: 10.1002/osp4.643
220
Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Tropical Doctor 2018; 48(2): 107 doi: 10.1177/0049475517742261
221
Saritha Krishna, Zhoumeng Lin, Claire B. de La Serre, John J. Wagner, Donald H. Harn, Lacey M. Pepples, Dylan M. Djani, Matthew T. Weber, Leena Srivastava, Nikolay M. Filipov. Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake. Physiology & Behavior 2016; 157: 196 doi: 10.1016/j.physbeh.2016.02.007
222
John Vizuete, Alfredo Camero, Mazyar Malakouti, Karthik Garapati, Julio Gutierrez. Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies. Journal of Clinical and Translational Hepatology 2017; 5(1): 67 doi: 10.14218/JCTH.2016.00061
223
Nissar U. Ashraf, Mohammad Altaf. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease. Mutation Research/Reviews in Mutation Research 2018; 778: 1 doi: 10.1016/j.mrrev.2018.07.002
224
Maya Spaur, Anne E. Nigra, Tiffany R. Sanchez, Ana Navas-Acien, Mariana Lazo, Hui-Chen Wu. Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18. Environmental Research 2022; 213: 113647 doi: 10.1016/j.envres.2022.113647
225
Yuan Yuan, Hisao Naito, Tamie Nakajima. Cholesterol - Good, Bad and the Heart. 2018;  doi: 10.5772/intechopen.76199
226
Sabine Hörist-Kollmann, Jeanette Strametz-Juranek. Female Dietary Patterns and the Pathogenesis of NAFLD. Gender and the Genome 2018; 2(2): 49 doi: 10.1177/2470289718787091
227
Olah Hakim, Oluwatoyosi Bello, Meera Ladwa, Dimitra Christodoulou, Esma Bulut, Haris Shuaib, Janet L. Peacock, A. Margot Umpleby, Geoff Charles-Edwards, Stephanie A. Amiel, Louise M. Goff. Ethnic differences in hepatic, pancreatic, muscular and visceral fat deposition in healthy men of white European and black west African ethnicity. Diabetes Research and Clinical Practice 2019; 156: 107866 doi: 10.1016/j.diabres.2019.107866
228
Daniel A Giles, Maria E Moreno-Fernandez, Traci E Stankiewicz, Simon Graspeuntner, Monica Cappelletti, David Wu, Rajib Mukherjee, Calvin C Chan, Matthew J Lawson, Jared Klarquist, Annika Sünderhauf, Samir Softic, C Ronald Kahn, Kerstin Stemmer, Yoichiro Iwakura, Bruce J Aronow, Rebekah Karns, Kris A Steinbrecher, Christopher L Karp, Rachel Sheridan, Shiva K Shanmukhappa, Damien Reynaud, David B Haslam, Christian Sina, Jan Rupp, Simon P Hogan, Senad Divanovic. Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. Nature Medicine 2017; 23(7): 829 doi: 10.1038/nm.4346
229
Brian J. Engel, Vincenzo Paolillo, Md. Nasir Uddin, Kristyn A. Gonzales, Kathryn M. McGinnis, Margie N. Sutton, Madhavi Patnana, Brian J. Grindel, Gregory J. Gores, David Piwnica-Worms, Laura Beretta, Federica Pisaneschi, Seth T. Gammon, Steven W. Millward. Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging. Cancers 2023; 15(15): 3787 doi: 10.3390/cancers15153787
230
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
231
Lourianne Nascimento Cavalcante, Jun Porto, Daniel Mazo, Adhemar Longatto-Filho, José Tadeu Stefano, Andre Castro Lyra, Flair Jose Carrilho, Rui Manuel Reis, Venâncio A.F. Alves, Arun J. Sanyal, Claudia P Oliveira. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. Annals of Hepatology 2022; 27(6): 100728 doi: 10.1016/j.aohep.2022.100728
232
Lindsey S Treviño, Tiffany A Katz. Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease. Endocrinology 2018; 159(1): 20 doi: 10.1210/en.2017-00887
233
Nader Lessan. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 161 doi: 10.1002/9781118924938.ch18
234
Caihua Wang, Chunpeng Zhu, Liming Shao, Jun Ye, Yimin Shen, Yuezhong Ren. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. Mediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/7659509
235
Ming Song, Miriam B. Vos, Craig J. McClain. Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD. Nutrients 2018; 10(11): 1815 doi: 10.3390/nu10111815
236
Tanja Cvitanović Tomaš, Žiga Urlep, Miha Moškon, Miha Mraz, Damjana Rozman. LiverSex Computational Model: Sexual Aspects in Hepatic Metabolism and Abnormalities. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00360
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345